Could I order a new chequebook, please? https://www.khamarbd.com/stmap_99gkrch.html?levitra.ansaid.savitra pharma service agentur hamburg gmbh  The study is codenamed ENCHANT-1. It indicated that 4 patients had achieved a very objective tumor-response. SNTA has said that it will be continuing with the enrollment of 33 patients in each one of the 2 patient-groups that are being tested in this study. Now the trial will study a combination of ganetespib and paclitaxel, a widely-used cancer drug.